+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Sleep Apnea - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Asthma - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Asthma - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • February 2026
  • 200 Pages
  • Global
From
Asthma - Competitive Landscape, 2026 - Product Thumbnail Image

Asthma - Competitive Landscape, 2026

  • Report
  • January 2026
  • 240 Pages
  • Global
From
From
From
From
From
From
Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
ARDS - Pipeline Insight, 2025 - Product Thumbnail Image

ARDS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Chronic Bronchitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Bronchitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Bronchitis - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Sleep Apnoea Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnoea Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 250 Pages
  • Global
From
Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Emphysema - Pipeline Insight, 2025 - Product Thumbnail Image

Emphysema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more